Actively Recruiting
Clinical Pre-screening Protocol for Ovarian Cancer
Led by Allarity Therapeutics · Updated on 2025-10-30
60
Participants Needed
5
Research Sites
398 weeks
Total Duration
On this page
Sponsors
A
Allarity Therapeutics
Lead Sponsor
A
Amarex Clinical Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
The patient's local archival tumor tissue (FFPE) from original tumor, or from the metastatic tissue, will be collected to potentially identify if they - at a later stage of their disease - will be likely to benefit from treatment with any of the investigational cancer drugs available to Allarity Therapeutics. Data from this study can further be used to explore in a retrospective fashion, sensitivity to other chemotherapeutic drugs previously used in the treatment of their ovarian cancer, to investigate whether or not the DRP® method can predict and confirm the obtained sensitivity to the prior given drugs as well as prospective analyses guiding the Investigators on future treatments.
CONDITIONS
Official Title
Clinical Pre-screening Protocol for Ovarian Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with histological confirmed epithelia ovarian cancer
- Patients must have platinum-resistant disease, defined as progression within 6 months after the last dose of platinum-based chemotherapy, or are platinum ineligible
- Patients have received no more than one prior line of therapy in the platinum resistant or platinum ineligible setting
- FFPE tumor tissue available
You will not qualify if you...
- Patients who have platinum-refractory disease, defined as progression during the last platinum-based chemotherapy
- Other malignancy with exception of any stage I and II cancer that is deemed cured by the Investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Completed
2
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States, 73104
Actively Recruiting
3
Swedish Center for Research and Innovation
Seattle, Washington, United States, 98122
Actively Recruiting
4
Beatson West of Scotland Cancer Centre
Glasgow, Scotland, United Kingdom, G12 0YN
Active, Not Recruiting
5
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital
London, United Kingdom
Active, Not Recruiting
Research Team
U
US: Kathleen Moore
CONTACT
E
Europe: Rebecca Kristeleit
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here